MoneyWorks4Me

Windlas Biotech - Quaterly Results

04 Aug 2022 Evaluate
The company witnessed a 8.09% growth in the revenue at Rs. 1199.36 millions for the quarter ended June 2022 as compared to Rs. 1109.56 millions during the year-ago period.Good  Net Profit growth of 46.55% reported above the corresponding previous quarter figure of Rs. 66.87 millions to Rs. 98.00 millioins.Operating profit for the quarter ended June 2022 rose to 166.50 millions as compared to 130.74 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1199.36 1109.56 8.09 1199.36 1109.56 8.09 4659.30 4276.02 8.96
Other Income 28.58 6.89 314.80 28.58 6.89 314.80 67.06 30.94 116.74
PBIDT 166.50 130.74 27.35 166.50 130.74 27.35 596.01 577.86 3.14
Interest 3.50 4.82 -27.39 3.50 4.82 -27.39 14.17 12.90 9.84
PBDT 163.00 125.92 29.45 163.00 125.92 29.45 581.84 241.45 140.98
Depreciation 27.56 30.25 -8.89 27.56 30.25 -8.89 121.47 129.65 -6.31
PBT 135.44 95.67 41.57 135.44 95.67 41.57 460.37 111.80 311.78
TAX 37.44 28.80 30.00 37.44 28.80 30.00 74.76 61.70 21.17
Deferred Tax 0.96 -0.07 -1471.43 0.96 -0.07 -1471.43 -26.57 13.28 -300.08
PAT 98.00 66.87 46.55 98.00 66.87 46.55 385.61 50.10 669.68
Equity 108.97 91.04 19.69 108.97 91.04 19.69 108.97 64.11 69.97
PBIDTM(%) 13.88 11.78 17.82 13.88 11.78 17.82 12.79 13.51 -5.34
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..